Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company is headquartered in San Rafael, California and currently employs 61 full-time employees. The company went IPO on 2013-04-10. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a powered Knee Ankle Foot Orthosis; and Ekso EVO is a wearable upper body exoskeleton. The company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
Follow-Up Questions
Who is the CEO of Ekso Bionics Holdings Inc?
Mr. Scott Davis is the Chief Executive Officer of Ekso Bionics Holdings Inc, joining the firm since 2022.
What is the price performance of EKSO stock?
The current price of EKSO is $5.13, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Ekso Bionics Holdings Inc?
Ekso Bionics Holdings Inc belongs to Health Care industry and the sector is Health Care
What is Ekso Bionics Holdings Inc market cap?
Ekso Bionics Holdings Inc's current market cap is $13.3M
Is Ekso Bionics Holdings Inc a buy, sell, or hold?
According to wall street analysts, 4 analysts have made analyst ratings for Ekso Bionics Holdings Inc, including 2 strong buy, 5 buy, 1 hold, 0 sell, and 2 strong sell
